161 related articles for article (PubMed ID: 35045282)
1. The portrait of liver cancer is shaped by mitochondrial genetics.
Chattopadhyay M; Jenkins EC; Lechuga-Vieco AV; Nie K; Fiel MI; Rialdi A; Guccione E; Enriquez JA; Sia D; Lujambio A; Germain D
Cell Rep; 2022 Jan; 38(3):110254. PubMed ID: 35045282
[TBL] [Abstract][Full Text] [Related]
2. Mitohormesis, UPR
Kenny TC; Gomez ML; Germain D
Cancer Res; 2019 Dec; 79(24):6057-6066. PubMed ID: 31484668
[TBL] [Abstract][Full Text] [Related]
3. Parity predisposes breasts to the oncogenic action of PAPP-A and activation of the collagen receptor DDR2.
Slocum E; Craig A; Villanueva A; Germain D
Breast Cancer Res; 2019 May; 21(1):56. PubMed ID: 31046834
[TBL] [Abstract][Full Text] [Related]
4. Multi-regional sequencing reveals intratumor heterogeneity and positive selection of somatic mtDNA mutations in hepatocellular carcinoma and colorectal cancer.
Li X; Guo X; Li D; Du X; Yin C; Chen C; Fang W; Bian Z; Zhang J; Li B; Yang H; Xing J
Int J Cancer; 2018 Sep; 143(5):1143-1152. PubMed ID: 29569724
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia induced HMGB1 and mitochondrial DNA interactions mediate tumor growth in hepatocellular carcinoma through Toll-like receptor 9.
Liu Y; Yan W; Tohme S; Chen M; Fu Y; Tian D; Lotze M; Tang D; Tsung A
J Hepatol; 2015 Jul; 63(1):114-21. PubMed ID: 25681553
[TBL] [Abstract][Full Text] [Related]
6. Placental growth factor inhibition modulates the interplay between hypoxia and unfolded protein response in hepatocellular carcinoma.
Vandewynckel YP; Laukens D; Devisscher L; Bogaerts E; Paridaens A; Van den Bussche A; Raevens S; Verhelst X; Van Steenkiste C; Jonckx B; Libbrecht L; Geerts A; Carmeliet P; Van Vlierberghe H
BMC Cancer; 2016 Jan; 16():9. PubMed ID: 26753564
[TBL] [Abstract][Full Text] [Related]
7. Impact of an MT-RNR1 Gene Polymorphism on Hepatocellular Carcinoma Progression and Clinical Characteristics.
Lin YH; Chu YD; Lim SN; Chen CW; Yeh CT; Lin WR
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498721
[TBL] [Abstract][Full Text] [Related]
8. NGS-based profiling reveals a critical contributing role of somatic D-loop mtDNA mutations in HBV-related hepatocarcinogenesis.
Yin C; Li DY; Guo X; Cao HY; Chen YB; Zhou F; Ge NJ; Liu Y; Guo SS; Zhao Z; Yang HS; Xing JL
Ann Oncol; 2019 Jun; 30(6):953-962. PubMed ID: 30887045
[TBL] [Abstract][Full Text] [Related]
9. Hepatocellular carcinoma-associated depletion of the netrin-1 receptor Uncoordinated Phenotype-5A (UNC5A) skews the hepatic unfolded protein response towards prosurvival outcomes.
Barnault R; Lahlali T; Plissonnier ML; Romero-López C; Laverdure N; Ducarouge B; Rivoire M; Mehlen P; Zoulim F; Parent R
Biochem Biophys Res Commun; 2018 Jan; 495(4):2425-2431. PubMed ID: 29277614
[TBL] [Abstract][Full Text] [Related]
10. Entropy of mitochondrial DNA circulating in blood is associated with hepatocellular carcinoma.
Campo DS; Nayak V; Srinivasamoorthy G; Khudyakov Y
BMC Med Genomics; 2019 Jun; 12(Suppl 4):74. PubMed ID: 31167647
[TBL] [Abstract][Full Text] [Related]
11. Somatic mutations in the D-loop and decrease in the copy number of mitochondrial DNA in human hepatocellular carcinoma.
Lee HC; Li SH; Lin JC; Wu CC; Yeh DC; Wei YH
Mutat Res; 2004 Mar; 547(1-2):71-8. PubMed ID: 15013701
[TBL] [Abstract][Full Text] [Related]
12. Correlation between clinical characteristics and mitochondrial D-loop DNA mutations in hepatocellular carcinoma.
Tamori A; Nishiguchi S; Nishikawa M; Kubo S; Koh N; Hirohashi K; Shiomi S; Inoue M
J Gastroenterol; 2004 Nov; 39(11):1063-8. PubMed ID: 15580399
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial DNA alterations and mitochondrial dysfunction in the progression of hepatocellular carcinoma.
Hsu CC; Lee HC; Wei YH
World J Gastroenterol; 2013 Dec; 19(47):8880-6. PubMed ID: 24379611
[TBL] [Abstract][Full Text] [Related]
14. Plasma Cell Polarization to the Immunoglobulin G Phenotype in Hepatocellular Carcinomas Involves Epigenetic Alterations and Promotes Hepatoma Progression in Mice.
Wei Y; Lao XM; Xiao X; Wang XY; Wu ZJ; Zeng QH; Wu CY; Wu RQ; Chen ZX; Zheng L; Li B; Kuang DM
Gastroenterology; 2019 May; 156(6):1890-1904.e16. PubMed ID: 30711627
[TBL] [Abstract][Full Text] [Related]
15. Lymphocytic mitochondrial DNA deletions, biochemical folate status and hepatocellular carcinoma susceptibility in a case-control study.
Wu MY; Kuo CS; Lin CY; Lu CL; Syu Huang RF
Br J Nutr; 2009 Sep; 102(5):715-21. PubMed ID: 19331700
[TBL] [Abstract][Full Text] [Related]
16. Evidence of Neutral Evolution of Mitochondrial DNA in Human Hepatocellular Carcinoma.
Liu Q; Lin D; Li M; Gu Z; Zhao Y
Genome Biol Evol; 2019 Oct; 11(10):2909-2916. PubMed ID: 31599941
[TBL] [Abstract][Full Text] [Related]
17. Selected mitochondrial DNA landscapes activate the SIRT3 axis of the UPR
Kenny TC; Hart P; Ragazzi M; Sersinghe M; Chipuk J; Sagar MAK; Eliceiri KW; LaFramboise T; Grandhi S; Santos J; Riar AK; Papa L; D'Aurello M; Manfredi G; Bonini MG; Germain D
Oncogene; 2017 Aug; 36(31):4393-4404. PubMed ID: 28368421
[TBL] [Abstract][Full Text] [Related]
18. Somatic mutation of mitochondrial DNA in cancerous and noncancerous liver tissue in individuals with hepatocellular carcinoma.
Nishikawa M; Nishiguchi S; Shiomi S; Tamori A; Koh N; Takeda T; Kubo S; Hirohashi K; Kinoshita H; Sato E; Inoue M
Cancer Res; 2001 Mar; 61(5):1843-5. PubMed ID: 11280735
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of discoidin domain receptor 2 decreases tumor growth of hepatocellular carcinoma.
Park JW; Lee YS; Kim JS; Lee SK; Kim BH; Lee JA; Lee NO; Kim SH; Hong EK
J Cancer Res Clin Oncol; 2015 Nov; 141(11):1973-83. PubMed ID: 25842034
[TBL] [Abstract][Full Text] [Related]
20. Loss of mitochondrial DNA enhances angiogenic and invasive potential of hepatoma cells.
Cheon H; Moon HE; Lee MS; Kim SS
Oncol Rep; 2010 Mar; 23(3):779-86. PubMed ID: 20127020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
